# Single Arm on the Tolerability of Weekly Nab-paclitaxel

> **NCT01702844** · PHASE2 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 42 (actual)

## Conditions studied

- Non Small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** Nab-Paclitaxel

## Key facts

- **NCT ID:** NCT01702844
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-25
- **Primary completion:** 2017-06-23
- **Final completion:** 2019-07-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702844, "Single Arm on the Tolerability of Weekly Nab-paclitaxel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01702844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*